Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 20 min ago
Peer-reviewedCC BY-NC-NDInternal Medicine

Warm Autoimmune Hemolytic Anemia Associated with Pancreatic Adenocarcinoma Showing Ectopic Expression of Band 3 Protein: A Case Report

Abstract

Autoimmune hemolytic anemia (AIHA) is rare in solid tumors and may represent a paraneoplastic phenomenon. We describe the case of a 73-year-old woman with unresectable pancreatic adenocarcinoma who developed steroid-refractory warm AIHA. Prednisolone partially improved her anemia but not her hemolysis. Chemotherapy with modified FOLFIRINOX followed by gemcitabine plus nab-paclitaxel improved both the tumor and anemia, enabling steroid tapering. Conversion surgery revealed the ectopic expression of band 3 in tumor cells. This case suggests that anti-band 3 antibodies may mediate paraneoplastic AIHA and emphasizes the importance of tumor control in steroid-refractory cases.

Related

  1. Immunohistochemical Expression of M30, BCL-2, BAX, and Ki-67 in Pancreatic Ductal Adenocarcinoma: Association with Clinicopathological Features
    Betül Demirciler Yavaş, Sezgin Yılmaz
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Non-Invasive Assessment of SMAD4 Expression Status in Pancreatic Ductal Adenocarcinoma: Diagnostic Value of T1ρ-Weighted Imaging Combined with Clinical Parameters
    Ke Li, Rui Guo, Jing Li +5
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. HMGA2 Expression in Pancreatic Ductal Adenocarcinoma Controls Tumor Microenvironment and Immunosuppression via IL1α
    N. Yamamoto, S. Dobersch, T. M. Robertson +20
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  4. Arrest-associated transcriptional programmes outweigh apoptosis-associated programmes in treatment-naive pancreatic ductal adenocarcinoma
    C. A. Obuekwe, B. T. Ogunoye, A. Adelaja +3
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  5. A MYC-LDHA-MCT4 expression program marks an SPP1/TREM2-centered macrophage state in pancreatic ductal adenocarcinoma
    Qianqian Ma, Hequn He, Ting Liu +4
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
BibTeX
@article{goto2026warm,
  title = {{Warm Autoimmune Hemolytic Anemia Associated with Pancreatic Adenocarcinoma Showing Ectopic Expression of Band 3 Protein: A Case Report}},
  author = {Akari Goto and Makoto Yoshida and Ryosei Murai and Hiroto Horiguchi and Satoshi Iyama and Kazuma Ishikawa and Satoshi Takahashi and Kohichi Takada and Masayoshi Kobune},
  journal = {Internal Medicine},
  year = {2026},
  month = sep,
  doi = {10.2169/internalmedicine.6765-25},
  url = {https://www.jstage.jst.go.jp/article/internalmedicine/65/18/65_6765-25/_article},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Warm Autoimmune Hemolytic Anemia Associated with Pancreatic Adenocarcinoma Showing Ectopic Expression of Band 3 Protein: A Case Report
AU  - Akari Goto
AU  - Makoto Yoshida
AU  - Ryosei Murai
AU  - Hiroto Horiguchi
AU  - Satoshi Iyama
AU  - Kazuma Ishikawa
AU  - Satoshi Takahashi
AU  - Kohichi Takada
AU  - Masayoshi Kobune
PY  - 2026
DA  - 2026/09/15
JO  - Internal Medicine
DO  - 10.2169/internalmedicine.6765-25
UR  - https://www.jstage.jst.go.jp/article/internalmedicine/65/18/65_6765-25/_article
AB  - Autoimmune hemolytic anemia (AIHA) is rare in solid tumors and may represent a paraneoplastic phenomenon. We describe the case of a 73-year-old woman with unresectable pancreatic adenocarcinoma who developed steroid-refractory warm AIHA. Prednisolone partially improved her anemia but not her hemolysis. Chemotherapy with modified FOLFIRINOX followed by gemcitabine plus nab-paclitaxel improved both the tumor and anemia, enabling steroid tapering. Conversion surgery revealed the ectopic expression of band 3 in tumor cells. This case suggests that anti-band 3 antibodies may mediate paraneoplastic AIHA and emphasizes the importance of tumor control in steroid-refractory cases.
SN  - 1349-7235
SN  - 0918-2918
ER  -